Dina Khalaf

CLIN ASO PROF

MD-MEDICINE

sort by:

GRANT
A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)
National Institute of Health Nci3 Mar 2026 - 19 Oct 2031
Active
GRANT
A MyeloMATCH Treatment Trial: A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2 Mutated Myelodysplastic Syndrome
National Institute of Health Nci18 Oct 2025 - 17 Oct 2030
Active
GRANT
Master Screening and Reassessment Protocol (MSRP) for the NCI MYELOMATCH Trials
National Institute of Health Nci18 Oct 2025 - 28 Feb 2030
Active
GRANT
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
Swog Clinical Trials Initiative23 Feb 2023 - 6 Aug 2026
Expired
GRANT
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
National Institute of Health Nci23 Feb 2023 - 28 Feb 2032
Active
GRANT
LLS funding for Improving risk assessment of AML with a precision genomic strategy to assess mutation clearance#
Blood Cancer United6 Feb 2020 - 18 Jun 2027
Active

GRANTS